DHR vs MS: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Morgan Stanley — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
Morgan Stanley · Financial Services
$206.27
+15.9% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
MS |
| Current Price |
$221.12 |
$206.27 |
| Fair Value Estimate |
$286.52 |
$239.00 |
| Upside to Fair Value |
+29.6%
|
+15.9%
|
| Market Cap |
$155.4B |
$325.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
23.5x
|
| Price / Sales |
6.2x
|
2.6x
|
| Price / FCF |
28.5x
|
—
|
| Revenue Growth YoY |
+5.5%
|
+22.4%
|
| Gross Margin |
58.5%
|
59.7%
|
| Operating Margin |
20.4%
|
20.7%
|
| Return on Equity |
7.7%
|
18.1%
|
| Dividend Yield |
0.65% |
2.01% |
| FCF Yield |
3.51%
|
—
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Morgan Stanley is a diversified capital-markets and wealth-management franchise spanning institutional securities, advisor-led and self-directed wealth, workplace services, and investment management. Business quality is solid but inherently cyclical: it combines $8.084 trillion of wealth client assets and $2.004 trillion of investment-management AUM/AUS with a strengthening 15.5% institutional pe…
Accumulation Zones
| Metric |
DHR |
MS |
| Zone Low |
$214.89 |
$179.25 |
| Zone High |
$243.54 |
$203.15 |
| In Buy Zone? |
Yes
|
No
|